Objective To understand clinician use of and opinions about telemedicine for opioid use
disorder (tele-OUD) during the COVID-19 pandemic. Methods An electronic national survey …

Background During the pandemic, there was a dramatic shift to telemedicine for opioid use
disorder (OUD) treatment. Little is known about how clinician attitudes about telemedicine …

Importance Little is known about the potential implications of the rapid transition to telehealth
during the COVID-19 pandemic for treatment of opioid use disorder (OUD). Objective To …

Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Abstract Background The Ryan Haight Act generally requires a clinician to conduct an in-
person visit before prescribing an opioid use disorder (OUD) medication. This requirement …

The coronavirus disease pandemic of 2019 (COVID-19) has created significant economic
and societal burden, with mortality currently exceeding 615,000 and millions of others …

Background: The COVID-19 pandemic resulted in a marked increase in telehealth for the
provision of primary care-based opioid use disorder (OUD) treatment. This mixed methods …

Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Objective Telemedicine for opioid use disorder (tele-OUD) has the potential to increase
access to medications for OUD (MOUD). Fully virtual tele-OUD services, in which all care is …

Background: Methadone and buprenorphine are effective medications for opioid use
disorder (MOUD) that are highly regulated in the United States. The on-going opioid crisis …